ACME Holdings to list on November 13; Here are key things to know before listing

It’s a hectic listing day today. Along with the big bang Swiggy listing, ACME Solar Holdings is all set to hit the secondary markets on November 13. The IPO was subscribed 2.89 times while the retail portion was booked 3.25 times. The IPO was opened on November 06 and closed on November 08. The company raised Rs 2,900 crore. 

ACME Solar Holdings IPO GMP

The shares of ACME Solar Holdings were trading at a discount of 1.38% in the grey market. The GMP of ACME Solar Holding is indicating a disappointing listing. The grey market is an unofficial place to trade shares ahead of listing. Market participants keep an eye on GMP to track listing day gains. 

ACME Solar Holdings IPO Details

The company’s IPO price band ranged between Rs 275 to Rs 289 per equity share. The allotment of shares was finalised on November 11. Retail buyers could apply for 51 shares in an application and then in multiples of it. The 51 shares amount to Rs 14,739. There were different lot sizes for small and big NIIs. The small NII could invest a minimum of Rs 2,06,346 while big NIIs Rs 10,02,252. 

Also Read Will Swiggy IPO be a Hit or a Miss on listing day? A detailed analysis of Swiggy’s valuation Swiggy IPO to unlock Rs 9K-crore benefits for employees NTPC Green Energy IPO likely next week, eyes $12 billion valuation Zinka Logistics Solution (BlackBuck) IPO to open on November 13: Details on issue price, allotment date, GMP

About ACME Solar Holding 

ACME Solar Holdings is in the business of producing electricity from renewable energy sources. The company is one of the largest producers of electricity from wind and solar energy in India. ACME Solar Holdings specializes in the development, construction, ownership, operation, and maintenance of large-scale renewable energy projects. The company’s revenue is generated by selling electricity to various customers, including plants supported by the central and state governments.

Objectives of IPO

The company will be utilising the raised funds for the payment of certain borrowings availed by the company’s subsidiaries. Also, some part of the proceeds will be used for other general corporate purposes.  

BRLMs and Registrar

Nuvama Wealth Management, ICICI Securities, JM Financial, Kotak Mahindra Capital Company,

 » Read More

Related Articles

Mphasis posts modest revenue, profit growth in Q3

Mphasis reported a sequential revenue growth of 0.8% to Rs 3,561.3 crore and a net profit of Rs 427.9 crore, up 1.1%, for the quarter ended December.  “We continue to stay focused on driving deal activity and closures, as we get on the other side of the macro cycle. AI is driving a fundamental shift

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Stay Connected

0FansLike
0FollowersFollow
0SubscribersSubscribe
- Advertisement -

Latest Articles

Mphasis posts modest revenue, profit growth in Q3

Mphasis reported a sequential revenue growth of 0.8% to Rs 3,561.3 crore and a net profit of Rs 427.9 crore, up 1.1%, for the quarter ended December.  “We continue to stay focused on driving deal activity and closures, as we get on the other side of the macro cycle. AI is driving a fundamental shift

Q3FY25 Results: Thyrocare reports 30 percent rise in profit; Revenue stood at Rs 165.9 Crore

Thyrocare on Thursday announced its financial results for the quarter and nine months ended December 31, 2024. According to the company’s statement, the diagnostics major reported revenue of Rs. 165.9 Cr in Q3FY25 with a growth of 23 percent YoY. According to the company’s statement, Thyrocare’s consolidated revenue increased by 23% year-over-year (YoY) with Pathology

Gold prices soar to new peak of Rs 82,900 per 10 gm; silver drops by Rs 500

Gold prices rose Rs 170 to hit a fresh record high of Rs 82,900 per 10 grams in the national capital on Thursday amid a positive global trend, according to the All India Sarafa Association. The precious metal had closed at Rs 82,730 per 10 grams on Wednesday. In about one year, the precious metal

Good news for taxpayers! Govt removes THESE difficulties to ensure more tax cases are settled – Check details!

Good news for taxpayers! The Finance Ministry has made some changes to the Direct Tax Vivad Se Vishwas Scheme, 2024, removing “difficulties” that arose due to certain situations for taxpayers. This update in the scheme will bring relief to taxpayers who wanted to apply for the scheme but could not do so earlier. “CBDT…makes the

Johnnie Walker-maker United Spirits posts Q3 profit decline of 4.29% to Rs 335 crore, revenue up 11.06% YoY

United Spirits, which makes Smirnoff vodka, on Thursday reported a profit of Rs 335 crore for the third quarter of FY25, posting a decline of 4.29 per cent in comparison to Rs 350 crore during the corresponding quarter of previous financial year. It posted revenue from operations at Rs 7,732 crore, reporting a growth of